Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Arctic Bioscience AS: Arctic Bioscience - Primary insiders participating in convertible loan facility

Arctic Bioscience
Read the release

Reference is made to the stock exchange release from earlier today, 13th January 2025, regarding new funding, including a convertible loan facility of NOK 15 million.

The following primary insiders, or closely related companies to primary insiders, are a part of the total investor consortium:

  • Ronja Capital Investment AS, a company closely related to Board Member Tore Tønseth, NOK 3,0 million
  • Vartdal Holding AS, a company closely related to Board Member Jan Endre Vartdal, NOK 1,0 million
  • Brødrene Vartdal AS, a company closely related to Board Member Jan Endre Vartdal, NOK 1,0 million
  • Ajea Invest AS, a company closely related to Board Member Asbjørn Solevågseide, NOK 0,5 million
  • Eros AS, a company closely related to Board Member Per Magne Eggesbø, NOK 0,6 million
  • Siglar AS, a company closely related to Chairman of the Board Harald Nordal, NOK 0,15 million
  • Clu Invest AS, a company closely related to CEO Christer L. Valderhaug, NOK 0,1 million
  • Runhild Gammelsæter, Medical Director, NOK 0,05 million

This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 and the Norwegian Securities Trading Act § 5-12.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.